The MK2 pathway may also promote fibrosis, as MK2 inhibition was shown by us to decrease fibrosis in inflammatory bowel disease (IBD) models [16] and by others in pulmonary and cardiac fibrosis [17,18]. This evidence concerns the gene MAPKAPK2 and inflammatory bowel disease.